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Background: This study was conducted to elucidate the prevalence of Helicobacter pylori in patients with
a perforated duodenal ulcer and to determine whether eradication of H. pylori prevent ulcer recurrence
following simple repair of the perforation.
Patients and method: Eighty-three patients with perforated duodenal ulcer (68 males); mean age was
47.8 years 7.2. Antral mucosal biopsies (to determine the status of HP by rapid urease test, culture and
histological examination/staining) were obtained during laparotomy by passing a biopsy forceps through
the perforation site. H. pylori positive patients who had undergone patch repair were randomized into
the eradication group who received amoxicillin, metranidazole plus omperazole and the control group
was given omeprazole alone. Follow-up endoscopy and antral biopsies were performed at 8 weeks, 16
weeks and 1 year to show ulcer healing and determine H. pylori state.
Results: Of 77 patients in the study, 65 patients (84.8%) had H. pylori. These patients were randomly
divided into the triple therapy group (34 patients) and the control group (31 patients). Eradication of
H. pylori was signiﬁcantly higher in the triple therapy group than the control group and initial ulcer
healing was signiﬁcantly better in the eradication group. After 1 year, ulcer recurrence was (6.1%) in the
eradication group vs. (29.6%) in the control group (P¼ 0.001).
Conclusion: H. pylori was present in a high proportion of patients with duodenal ulcer perforation.
Eradication of H. pylori after simple closure of a perforated duodenal ulcer reduced the incidence of
recurrent ulcer.
 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Perforation is a serious and potentially fatal complication of
duodenal ulcer. The incidence of perforated duodenal ulcer has not
decreased despite advances in medical treatment.1 Simple closure
was initially and remains one of the treatments of perforated
duodenal ulcer. However, the long-term results of omental patch
repair for perforated duodenal ulcer are unsatisfactory; a high
incidence of ulcer recurrence has been reported, reaching 40–50%
in some series.2–4 Use of acid suppressing agents to reduce ulcer
recurrence after simple patch closure produced debatableand Tamer Yousef wrote the
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ciates Ltd. Published by Elsevier Ltresults.5–7 Immediate deﬁnite surgery although is effective with
low recurrence rate, is associated with long-term side effects.5
Helicobacter pylori (H. pylori) has been described as an oppor-
tunistic pathogen attracted by changes in the gastric mucosa
caused by inﬂammation and ulcer.11 However, its role in duodenal
perforation has been investigated extensively and the results are
conﬂicting.6–10 Eradication of H. pylori heals most uncomplicated
duodenal ulcers and prevent relapse.8–12
The aim of this study was to elucidate the prevalence of H. pylori
in patients with a perforated duodenal ulcer and to determine
whether eradication of H. pylori prevent ulcer recurrence following
simple repair of the perforation.
2. Patients and methods
Of the 83 patients admitted with perforated duodenal ulcer
between March 2005 and January 2007 at the Emergency Man-
soura University Hospital, 77 patients were treated by simple
closure and theywere included in our study. Exclusion criteriawered. All rights reserved.
Table 1
Demographic data of the all patients (83 patients) with perforated duodenal ulcer.
Variables No (%)
Age 47.8 7.2
Sex
Male 68 (81.9%)
Female 15 (18.1%)
Smoking
Yes 56 (67.5%)
No 27 (32.5%)
NSAID intake
Yes 21 (25.3%)
No 62 (74.7%)
Exclusion 6
Age above 75 years 2
Deﬁnite surgery 4
Patients in the study 77
Age (mean SD) 46.7 10.2
Sex
Male 64 (83.1%)
Female 13 (17.9%)
H. pylori status
Positive 65 (84.4%)
Negative 12 (15.6%)
NSAID: non-steroidal anti-inﬂammatory drug, and H. pylori: Helicobacter pylori.
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of antibiotics, H2 antagonists or proton pump inhibitors within 4
weeks before admission, sealed off perforation, previous gastrec-
tomy or vagotomy or patients with perforated gastric ulcers.
Demographic data, history of dyspepsia for more than 3 months,
smoking and the use of non-steroidal anti-inﬂammatory drug
(NSAIDs) were recorded at time of admission.
All patients were resuscitated before surgery. Informed consent
was obtained from every patient for surgical exploration and
inclusion in the study. Intravenous cefuroxime (1.5 gm) was
administered during induction of anesthesia; no other antibiotics
or acid suppressing treatment was prescribed before the operation.
When duodenal ulcer perforation was conﬁrmed at laparotomy,
multiple antral mucosal biopsies were obtained by passing a biopsy
forceps through the perforation site. Antral biopsies were exam-
ined as follows:- one piece for a rapid urease test (Campylobacter-
like organism CLO, Delta West, West Australia); three pieces
transported in brain–heart solution at room temperature for
subsequent culture (Columbia agar supplemented with 5% horse
blood at 37 C for 5 days under microaerophilic conditions) and the
presence of H. pyloriwas conﬁrmed by Gram stain and biochemical
tests (for oxidase, catalase and urease); and three pieces were ﬁxed
with 10% buffered formalin for histological examination after
Haematoxylin and Eosin (H & E) staining. Patients were considered
to be H. pylori positive when two of three tests showed presence of
the bacteria.14
Omental patch repair was then commenced unless there were
indications for deﬁnitive acid reduction surgery (large perfo-
ration> 1 cm in diameter not amenable to simple closure or
perforation concomitant with obstruction). Patients who under-
went immediate deﬁnitive surgery were excluded from the study.
Peritoneal lavage was performed before closure of the abdominal
incision. Intravenous cefuroxime was continued every 8 h for 3
days after surgery.
H. pylori positive patients who had undergone patch repair were
eligible for randomization. After resuming an oral diet, patients
were randomly assigned to one of the two treatment options by
opening a sealed envelop. Patients in group I: eradication group
(triple therapy) received 1 week of oral amoxicillin 750 three times
daily, metranidazole 500 mg twice daily for 10 days and omepra-
zole 40 mg for 4 weeks. Patients in group II (control group) were
given omeprazole alone 40 mg daily for 4 weeks.
All patients were called back for personal interview and follow-
up endoscopy at 8 weeks and after 1 year. At each endoscopy,
mucosal ulceration of 5 mm or more in the duodenum was
considered as persistent or recurrent ulcer.13 Ulcer healing was
deﬁned as either complete re-epithelialization of the duodenal
mucosa or presence of a scar.14 Endoscopic antral biopsies were
obtained to reevaluate the H. pylori status. Additional biopsies were
taken from the body of the stomach to avoid false negative results
secondary to proximal gastric migration of the bacterium after
therapy.
All patients with complete ulcer healing on the scheduled
endoscopy were then interviewed every 6 months. Maintenance
acid suppression agents were not prescribed during follow up
period. Repeated endoscopic examination was performed when-
ever the patients were symptomatic.
For patients who had ulcers which was not healed at 8 weeks,
another 4 weeks course of omeprazole 20 mg twice daily was
prescribed and a second endoscopy was scheduled at 16 weeks.
Primary treatment failure was considered to be present if the
patients had persistent non-healing ulcer at 16 weeks.
Statistical analysis of data was performed using SPSS version 10.
For continuous variables, descriptive statistics were calculated and
were reported as mean SD. Categorical variables were described
using frequency distributions. The Student’s t-test for pairedsamples was used to detect differences in the means of continuous
variables and Chi-square test was used in cases with low expected
frequencies (P-value< 0.05 was considered to be signiﬁcant).
3. Results
From March 2005 to January 2007 at the Emergency Mansoura
University Hospital, 83 patients (68 male and 15 female) with
a mean age of 47.8 years 7.2 were found to have perforated
duodenal ulcer at laparotomy. Six patients were excluded: two
were older than 75 years and four required deﬁnitive operation. Of
the remaining 77 patients, 65 (84.8%) were infected with H. pylori
(Table 1). Patients with positiveH. pyloriwere randomly assigned to
one of the two treatment options by opening sealed envelops:- 34
patients were assigned to triple therapy (the eradication group) and
31 patients to omeprazole alone (the control group). The two
groups were comparable in age, sex, smoking habit, use of NSAID,
size of perforation, severity of peritonitis and postoperative
complications (Table 2).
H. pylori eradication was signiﬁcantly higher in the triple
therapy group than the omeprazole alone group (at 8 weeks 91.2%
vs. 22.6% and at 16 weeks 97.6% vs. 51.6%). Initial healing of ulcers at
8 weeks follow-up endoscopy was signiﬁcantly better in the
eradication group. There were 85.3% healed ulcers in the triple
therapy group and 48.4% in the omeprazole alone group (P< 0.05).
At 16 weeks endoscopy the healed ulcer rates increased to 97.6% in
the triple therapy group and 87.1% in the omeprazole group
(P¼ 0.48) (Table 3). Patients with documented ulcer healing were
scheduled for follow up visits following the study protocol.
After 1 year, three patients in the triple therapy group and
another four patients in the omeprazole group were lost to follow
up. They reported no signiﬁcant dyspeptic symptoms and refused
to undergo further endoscopic examination. Of the remaining 58
patients who followed the study protocol, 10 patients had ulcer
recurrence (Table 4). Two patients in the triple therapy group had
ulcer relapse: one patient was asymptomatic and had recurrent
ulcer diagnosed at the scheduled 1-year endoscopy, the other had
melena 7 months after the repair operation and was found to have
recurrent H. pylori infection. Of the eight patients with ulcer
recurrence in the omeprazole alone group, ﬁve were symptomatic
Table 2
Patients in triple therapy group and omeprazole alone group.
Variables Triple therapy (34) Omeprazole alone (31) P-value
Age (mean SD) 46 12.9 46.6 10.5 0.6
Sex
Male 32 (94.1%) 27 (87.1%) 0.413
Female 2 (5.9%) 4 (12.9%)
Smoking
Yes 29 (85.3%) 24 (77.4%) 0.7
No 5 (14.7%) 7 (22.6%)
NSAID
Yes 10 (29.4%) 9 (29.1%) 0.06
No 24 (70.6%) 22 (70.9%)
Dyspepsia> 3 months
Yes 27 (79.4%) 22 (70.9%) 0.09
No 7 (20.6%) 9 (29.1%)
Size of perforation (mm) 4.5 1.3 mm 4.6 1.5 mm 0.432
Stage of peritonitis
Chemical 24 (70.6%) 22 (70.9%) 0.83
Purulent 10 (29.4%) 9 (29.1%)
Postoperative complication
Wound infection 2 (5.9%) 3 (9.7%) 0.64
Chest infection 7(20.6%) 5 (16.2%) 0.75
Urine retention 1(2.95%) 0 –
Ileus 5(14.7%) 4 (12.9%) 0.54
Leakage 2 (5.9%) 1 (3.2%) 0.65
NSAID: non-steroidal anti-inﬂammatory drug.
Table 4
One year follow up (triple therapy vs. omeprazole alone group).
Triple therapy Omeprazole alone P-value
Patients with complete ulcer healing
at the end of 16 weeks follow up
33 27
H. pylori eradicated 28 (84.8%) 14 (51.9%) 0.05
Ulcer recurrence 2 (6.1%) 8 (29.6%) 0.001
Symptomatic ulcer recurrence 1 (3.03%) 5 (18.5%) 0.05
Pain 0 3
Bleeding 1 2
Obstruction 0 0
Reperforation 0 0
H. pylori positive in recurrent ulcer 1 (3.03%) 7 (25.9%) 0.01
H. pylori: Helicobacter pylori.
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were asymptomatic and had recurrent ulcer diagnosed at the
scheduled 1-year endoscopy. The difference in ulcer recurrence
between the two groups was statistically signiﬁcant [two (6.1%) in
the eradication group vs. eight (29.6%) in the omeprazole alone
group P¼ 0.001]. Eight of these 10 ulcer recurrences were associ-
ated with H. pylori, with seven in the omeprazole group and one in
the triple therapy group.
4. Discussion
Perforated duodenal ulcer is a common surgical emergency.
Simple omental patch repair is a quick procedure but results in
recurrent ulceration in up to 42% of patients.15–18 Because of the
unsatisfactory result of simple repair, immediate acid-reducing
procedures have been strongly advocated. Several prospective
randomized studies reported signiﬁcantly fewer ulcer recurrences
by adding immediate vagotomy to patch repair of ulcer perfora-
tion.13,19 Immediate deﬁnitive surgery requires a longer operative
time. It is not a procedure that can be carried out by most surgical
residents who are the front line medical personnel managing
patients with duodenal ulcer perforation. It is also associated withTable 3
Early follow up (8 weeks and 16 weeks) in (triple therapy vs. omeprazole alone
group).
Triple therapy Omeprazole alone P-value
Patients who underwent initial
follow up endoscopy
34 31
H. pylori eradication
At 8 weeks 31 (91.2%) 7 (22.6%) 0.001
At 16 weeks 33 (97.6%) 16 (51.6%) 0.05
Complete ulcer healing
At 8 weeks 29 (85.3%) 15 (48.4%) 0.05
At 16 weeks 33 (97.6%) 27 (87.1%) 0.48
H. pylori: Helicobacter pylori.a high incidence of postoperative complications like dumping
syndrome, loss of weight, or diarrhea.13,20–22
Although the relationship between H. pylori infection and peptic
ulcer has been well deﬁned, the relationship with perforated ulcer
is controversial.26 In our study, the frequency of H. pylori infection
in patients with perforated duodenal ulcer is 84.4%. This ﬁgure is
much higher than those reported by Reinbach et al (47%)10 and Chu
et al (47%)20 but is consistent with those reported by Juan et al
(73.9%),21 Enders et al (80.6%),13 Sebastian et al (83%),9 Matsukura
et al (95%),22 Jurg Metzger et al (73.3%)24 and Ng et al (70%),25
suggesting an association between H. pylori infection and duodenal
ulcer perforation.
Standard triple therapy was used in this study as it is a gold
standard for H. pylori eradication.23 Omeprazole was given to both
groups as it was considered unethical to leave patients with
a proven ulcer without antisecretory therapy. Eradication rate were
signiﬁcantly higher after triple therapy than omeprazole alone, at 8
weeks follow up it was (91.2% vs. 22.6% P¼ 0.001) and at 16 weeks
it became (97.6% vs. 51.6% P¼ 0.05). Kate et al23 reported eradica-
tion rate was higher in the eradication group than the ranitidine
alone group at 8 weeks (80% in the eradication group vs. 57% in the
ranitidine group). Enders Ng et al.13 showed that H. pylori eradi-
cation in the triple therapy group was signiﬁcantly higher than the
omeprazole alone group (84.3% vs. 16.7%, P< 0.001). Jurg Metzger
et al.24 reported the eradication rate was 96% with triple therapy.
In the present study, initial healing of ulcers shown at 8-week
follow up endoscopy was signiﬁcantly better in the eradication
group (85.3% healed ulcers in the triple therapy group and 48.4% in
the omeprazole alone group). After 1 year, two patients in the triple
therapy group had ulcer relapse, one patient had melena 7 months
after the perforation and was found to have recurrent H. pylori
infection. Of the eight patients with ulcer recurrence in the ome-
prazole alone group, ﬁve were symptomatic (three with severe
ulcer pain, two with melena). The difference in ulcer recurrence
between the two groups was statistically signiﬁcant [two (6.1%) in
the eradication group vs. eight (29.6%) in the omeprazole alone
group P¼ 0.001]. Eight of these 10 ulcer recurrences were associ-
ated with H. pylori, seven in the omeprazole group and one in the
triple therapy group.
Kate et al23 from India reported a study on 202 patients with
perforated duodenal ulcer treated by simple closure. These patients
were then randomly divided into two groups: one group received
eradication therapy and another group received ranitidine alone.
After a routine endoscopy at various follow up intervals, a clear
relationship was established between the persistence of H. pylori
infection and ulcer persistence or relapse. Enders Ng et al13 from
Hong Kong reported 51 out of 129 patients with perforated
duodenal ulcer treated by simple closure and eradication therapy.
After follow up for 1 year, two patients (4.8%) had endoscopic
recurrence, which was signiﬁcantly lower than those patients
without eradication therapy. In another study, Bose et al27 reported
that 60 out of 93 patients who had H. pylori infection received
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were available for follow up. H. pylori eradication was achieved in
43 (81.1%) patients. It was found that 8 of 43 (18.6%) patients in the
eradicated group had persistence or recurrence of ulcer as opposed
to 7 of 10 (70%) patients in the non-eradicated group. Tran et al28
from Vietnam reported that 111 patients were treated by simple
closure; 107 had H. pylori infection and received eradication
therapy. After 12 months 95 patients were available for followed
up. H. pylori eradication was achieved in 79 patients. Three of 79
(3.8%) patients in the eradicated group had persistence or recur-
rence of ulcer as opposed to 4 of 16 (25%) patients in the H. pylori
infected group. After 60 months only 62 patients were available for
follow up. Three of 40 (7.5%) patients in the eradicated group had
persistence ulcer as opposed to 3 of 22 (13.6%) patients in the
H. pylori infected group.
In light of the high prevalence of H. pylori infection and the few
recurrence after eradication, the bacterium is likely to be causally
related to the strong ulcer diathesis in patients with duodenal ulcer
perforation. H. pylori plays an important role in duodenal ulcer
recurrence following simple closure of perforated duodenal ulcer.
We concluded from these results that H. pylori was present in
a high proportion of patients with duodenal ulcer perforation.
Eradication of H. pylori after simple closure of a perforated
duodenal ulcer reduced the incidence of recurrent ulcer. H. pylori
infection should be assessed at operation and initial endoscopy. If
H. pylori infection is conﬁrmed, an appropriate eradication therapy
should be given.Conﬂict of interest statement
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